The peptide hormone angiotensin II (AII) 1 potently stimulates protein synthesis and induces cellular hypertrophy in cultured rat vascular SMC (1-4). This growth-promoting effect is mediated by the AT 1 receptor subtype, a member of the G protein-coupled receptors superfamily (4, 5). However, the molecular basis for the hypertrophic action of the hormone remains largely unknown. In vascular SMC, the augmented rate of protein synthesis induced by AII is associated with a widespread but selective increase in the content of highly abundant extracellular matrix (6 -8) and contractile proteins (9). The increased synthesis of proteins like ␣-actin, collagen, or thrombospondin is accompanied by a corresponding increase in their specific mRNAs, which is indicative of the importance of transcriptional control in the overall stimulation of protein synthesis (6 -9). In agreement with this notion, the transcriptional inhibitor actinomycin D can prevent AII-induced accumulation of proteins in chronically stimulated vascular SMC (2). 2 On the other hand, the global nature of the trophic effect of AII suggests that regulatory changes at the translational level are likely to be involved in the hormone response.The major locus of regulation in protein synthesis is generally at the initiation step of mRNA translation (for review, see Refs. 10 -12). This step is controlled by the concerted action of a number of initiation factors which are extensively regulated by phosphorylation/dephosphorylation mechanisms (13, 14). The rate-limiting step in translation initiation is the binding of mRNA to the small 40 S ribosomal subunit, which requires the participation of initiation factor eIF4F (15). eIF4F exists as a protein complex composed of three polypeptides: eIF4E (the cap-binding protein), eIF4G, and eIF4A, a RNA helicase. The interaction of eIF4F with the mRNA, followed by the unwinding of the mRNA 5Ј secondary structure facilitates the attachment of the 40 S ribosomal subunit which moves along the mRNA scanning for the initiator AUG codon (10 -12, 15). eIF4E is the least abundant among all initiation factors and thus a critical regulatory component of the protein synthetic machinery (16,17). Overexpression of eIF4E leads to deregulation of cell growth (18) and oncogenic transformation (19), whereas its depletion decreases protein synthesis (20). The activity of eIF4E is regulated by 4E-BP1 (also known as PHAS-I) and 4E-BP2, two recently identified proteins which specifically bind to eIF4E and inhibit cap-dependent translation (21, 22). Phosphorylation of 4E-BP1 in response to insulin causes its dissociation from eIF4E, thereby relieving translational inhibition (21,22). 4E-BP1 is phosphorylated by ERK2 on a single serine residue in vitro (23), and this phosphorylation markedly decreases the affinity of the protein for eIF4E (22). In cultured adipocytes, the epidermal growth factor-stimulated 4E-BP1 kinase activity elutes in two peaks that correspond to the peaks of ERK isoforms after anion exchange chromatography (29). Based on the...